HENZALT Trademark

Trademark Overview


On Wednesday, April 10, 2019, a trademark application was filed for HENZALT with the United States Patent and Trademark Office. The USPTO has given the HENZALT trademark a serial number of 88379996. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 12, 2022. This trademark is owned by Eli Lilly and Company. The HENZALT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
henzalt

General Information


Serial Number88379996
Word MarkHENZALT
Filing DateWednesday, April 10, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 12, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 11, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer's disease, atopic dermatitis, autoimmune diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, headaches, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, Parkinson's disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis
Translation of Words in MarkThe wording "HENZALT" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, April 27, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameEli Lilly and Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Party NameEli Lilly and Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndianapolis, IN 46285

Trademark Events


Event DateEvent Description
Monday, September 12, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 12, 2022ABANDONMENT - NO USE STATEMENT FILED
Friday, January 14, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 13, 2022SOU EXTENSION 5 GRANTED
Tuesday, January 11, 2022SOU EXTENSION 5 FILED
Tuesday, January 11, 2022SOU TEAS EXTENSION RECEIVED
Saturday, July 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 1, 2021SOU EXTENSION 4 GRANTED
Thursday, July 1, 2021SOU EXTENSION 4 FILED
Thursday, July 1, 2021SOU TEAS EXTENSION RECEIVED
Friday, January 15, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 13, 2021SOU EXTENSION 3 GRANTED
Wednesday, January 13, 2021SOU EXTENSION 3 FILED
Wednesday, January 13, 2021SOU TEAS EXTENSION RECEIVED
Friday, August 7, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 6, 2020SOU EXTENSION 2 GRANTED
Friday, July 10, 2020SOU EXTENSION 2 FILED
Thursday, August 6, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, July 10, 2020SOU TEAS EXTENSION RECEIVED
Friday, January 17, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 15, 2020SOU EXTENSION 1 GRANTED
Wednesday, January 15, 2020SOU EXTENSION 1 FILED
Wednesday, January 15, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, August 6, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 11, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 11, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 22, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, May 2, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 29, 2019ASSIGNED TO EXAMINER
Saturday, April 27, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 13, 2019NEW APPLICATION ENTERED